BioRem Revenue vs. Number Of Shares Shorted

BRM Stock  CAD 3.07  0.09  2.85%   
Taking into consideration BioRem's profitability measurements, BioRem Inc is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in January. Profitability indicators assess BioRem's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2004-09-30
Previous Quarter
7.3 M
Current Value
14.9 M
Quarterly Volatility
2.5 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Operating Cash Flow Sales Ratio is likely to climb to 0.02 in 2024, whereas Price To Sales Ratio is likely to drop 0.59 in 2024. At this time, BioRem's Operating Income is fairly stable compared to the past year. Income Before Tax is likely to climb to about 2.9 M in 2024, despite the fact that Total Other Income Expense Net is likely to grow to (282.1 K).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.340.279
Fairly Up
Very volatile
For BioRem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioRem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioRem Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioRem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioRem Inc over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between BioRem's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioRem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioRem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BioRem Inc Number Of Shares Shorted vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BioRem's current stock value. Our valuation model uses many indicators to compare BioRem value to that of its competitors to determine the firm's financial worth.
BioRem Inc is rated third in revenue category among its peers. It is rated fifth in number of shares shorted category among its peers . The ratio of Revenue to Number Of Shares Shorted for BioRem Inc is about  9,422 . At this time, BioRem's Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioRem's earnings, one of the primary drivers of an investment's value.

BioRem Revenue vs. Competition

BioRem Inc is rated third in revenue category among its peers. Market size based on revenue of Industrials industry is currently estimated at about 98.32 Million. BioRem totals roughly 25.17 Million in revenue claiming about 26% of equities under Industrials industry.

BioRem Number Of Shares Shorted vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

BioRem

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
25.17 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

BioRem

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
2.67 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

BioRem Number Of Shares Shorted Comparison

BioRem is currently under evaluation in number of shares shorted category among its peers.

BioRem Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BioRem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioRem will eventually generate negative long term returns. The profitability progress is the general direction of BioRem's change in net profit over the period of time. It can combine multiple indicators of BioRem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income1.3 M653.8 K
Operating Income3.1 M3.2 M
Income Before Tax2.8 M2.9 M
Total Other Income Expense Net-297 K-282.1 K
Net Income2.2 M2.3 M
Income Tax Expense609.7 K640.2 K
Net Income From Continuing Ops2.2 M1.3 M
Net Income Applicable To Common Shares1.5 M1.2 M
Net Interest Income-273.4 K-259.8 K
Change To Netincome396.8 K416.7 K
Net Income Per Share 0.14  0.13 
Income Quality 0.22  0.17 
Net Income Per E B T 0.78  1.14 

BioRem Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BioRem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioRem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioRem's important profitability drivers and their relationship over time.

Use BioRem in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioRem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRem will appreciate offsetting losses from the drop in the long position's value.

BioRem Pair Trading

BioRem Inc Pair Trading Analysis

The ability to find closely correlated positions to BioRem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioRem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioRem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioRem Inc to buy it.
The correlation of BioRem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioRem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioRem Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioRem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BioRem position

In addition to having BioRem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cigarettes Thematic Idea Now

Cigarettes
Cigarettes Theme
Tobacco makers and distributors across globe. The Cigarettes theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for BioRem Stock Analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.